Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 22
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Eur J Paediatr Neurol ; 20(1): 45-52, 2016 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-26586340

RESUMEN

OBJECTIVES: The incidence of tick-borne encephalitis (TBE) is increasing in many countries. Magnetic resonance imaging (MRI) in the course of TBE is not regularly performed in children. The aim of our study was evaluating MRI-findings of children and adolescents with TBE. PATIENTS AND METHODS: Retrospective evaluation of the charts and MRIs of patients who had been treated for TBE in the four participating hospitals in the last twenty years. RESULTS: 11 patients (5 male; age at TBE 3 weeks-15 9/12 years; mean 104.9 months) were included. MRI (within the first week after admission) revealed symmetric or asymmetric T2-hyperintensities in both thalami in 7/11 patients with additional bilateral lesions in putamen and/or caudate nucleus in 3 patients, and additional cortical lesions in 2 patients. Our youngest patient presented with T2-hyperintensities affecting the whole left cerebral hemisphere including white and grey matter and both cerebellar hemispheres. One patient had a minimal reversible T2-hyperintensity in the splenium of the corpus callosum (RHSCC). 3/11 patients had a normal MRI. 4/11 patients showed complete neurological recovery (2/4 with a normal MRI, RHSCC patient). 6/11 children survived with significant sequelae: hemiparesis (n = 4); cognitive deficits (n = 4); pharmacoresistant epilepsy (n = 2). One patient died of a malignant brain edema. DISCUSSION: A spectrum of MRI findings can be found in children with TBE, often showing involvement of the subcortical deep grey matter structures. In children presenting with a meningoencephalitis and bilateral thalamic involvement TBE should be included in the differential diagnosis.


Asunto(s)
Encefalitis Transmitida por Garrapatas/diagnóstico , Imagen por Resonancia Magnética/métodos , Adolescente , Edema Encefálico/etiología , Núcleo Caudado/patología , Corteza Cerebral/patología , Niño , Preescolar , Trastornos del Conocimiento/etiología , Cuerpo Calloso/patología , Epilepsia Refractaria/etiología , Encefalitis Transmitida por Garrapatas/complicaciones , Encefalitis Transmitida por Garrapatas/terapia , Femenino , Estudios de Seguimiento , Humanos , Lactante , Recién Nacido , Masculino , Paresia/etiología , Putamen/patología , Estudios Retrospectivos , Tálamo/patología , Resultado del Tratamiento
2.
Transpl Infect Dis ; 13(5): 524-30, 2011 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-21395956

RESUMEN

We present the case of a 49-year-old male patient with Epstein-Barr virus (EBV)-associated post-transplant lymphoproliferative disorder (PTLD) limited to the brain that occurred 6 months after allogeneic hematopoietic stem cell transplantation (HSCT). Clinical symptoms included mental confusion, ataxia, and diplopia. Magnetic resonance imaging (MRI) revealed cerebellar and periventricular lesions consistent with an inflammatory process. Cerebrospinal fluid (CSF) analysis, but not peripheral blood, was positive for EBV-DNA, but no malignant cells were found. Brain biopsy was not feasible because of low platelet counts. As we considered a diagnosis of either EBV-associated encephalitis or PTLD, the patient was treated with rituximab combined with antiviral therapy. However, the cerebral lesions progressed and follow-up CSF testing revealed immunoglobulin H clonality as evidence of a malignant process. Subsequent treatment attempts included 2 donor lymphocyte infusions (DLI). Despite treatment, the patient died from autopsy-proven PTLD within 8 weeks of the onset of symptoms. This case demonstrates the clinical and diagnostic challenges of primary cerebral PTLD in a patient following allogeneic HSCT.


Asunto(s)
Encefalitis Viral/virología , Infecciones por Virus de Epstein-Barr/complicaciones , Trasplante de Células Madre Hematopoyéticas/efectos adversos , Herpesvirus Humano 4 , Trastornos Linfoproliferativos/etiología , Anticuerpos Monoclonales de Origen Murino/uso terapéutico , Encéfalo/patología , Encefalitis Viral/complicaciones , Encefalitis Viral/patología , Infecciones por Virus de Epstein-Barr/tratamiento farmacológico , Resultado Fatal , Humanos , Factores Inmunológicos/uso terapéutico , Trastornos Linfoproliferativos/patología , Masculino , Persona de Mediana Edad , Rituximab
3.
Acta Microbiol Immunol Hung ; 57(3): 181-9, 2010 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-20870590

RESUMEN

It is proposed that hemophagocytic lymphohistiocytosis (HLH) and myelodysplastic syndromes (MDS) may be temporally distinct phases of pathophysiologically related disease processes. A significant subgroup of MDS may develop from subclinical HLH. In that case, HLH-like disease would chronically proceed with little disease activity or under occasional flares only, until it first becomes clinically apparent at the MDS stage. At the MDS stage, however, HLH activity may be easily overlooked by histological or cytogenetic means, since hemophagocytosis has fallen already largely silent. Current treatment options for HLH, like high-dose intravenous immunoglobulins (IVIG), may turn out to be helpful in MDS patients as well. In rare and extreme cases, Leptospira infection causes severe and life-threatening HLH. Thus, this proposal also implies that an insufficient, dysfunctional or misdirected immunological response to Leptospira infection may lead to MDS in the long run in a significant number of cases, which have not been recognized as Leptospira -triggered events in the first place. Infections by agents other than Leptospira may lead to subclinical HLH-like disease with MDS as a late stage as well.


Asunto(s)
Leptospira/fisiología , Leptospirosis/microbiología , Linfohistiocitosis Hemofagocítica/microbiología , Síndromes Mielodisplásicos/patología , Anciano , Progresión de la Enfermedad , Femenino , Humanos , Leptospirosis/inmunología , Linfohistiocitosis Hemofagocítica/inmunología , Linfohistiocitosis Hemofagocítica/patología , Masculino , Persona de Mediana Edad , Síndromes Mielodisplásicos/inmunología , Síndromes Mielodisplásicos/microbiología
4.
Euro Surveill ; 14(36)2009 Sep 10.
Artículo en Inglés | MEDLINE | ID: mdl-19758541

RESUMEN

Influenza A(H1N1)v virus was first identified in April 2009. A novel real-time RT-PCR for influenza A(H1N1)v virus was set up ad hoc and validated following industry-standard criteria. The lower limit of detection of the assay was 384 copies of viral RNA per ml of viral transport medium (95% confidence interval: 273-876 RNA copies/ml). Specificity was 100% as assessed on a panel of reference samples including seasonal human influenza A virus H1N1 and H3N2, highly pathogenic avian influenza A virus H5N1 and porcine influenza A virus H1N1, H1N2 and H3N2 samples. The real-time RT-PCR assay for the influenza A matrix gene recommended in 2007 by the World Health Organization was modified to work under the same reaction conditions as the influenza A(H1N1)v virus-specific test. Both assays were equally sensitive. Clinical applicability of both assays was demonstrated by screening of almost 2,000 suspected influenza (H1N1)v specimens, which included samples from the first cases of pandemic H1N1 influenza imported to Germany. Measuring influenza A(H1N1)v virus concentrations in 144 laboratory-confirmed samples yielded a median of 4.6 log RNA copies/ml. The new methodology proved its principle and might assist public health laboratories in the upcoming influenza pandemic.


Asunto(s)
Brotes de Enfermedades/estadística & datos numéricos , Subtipo H1N2 del Virus de la Influenza A/genética , Subtipo H1N2 del Virus de la Influenza A/aislamiento & purificación , Gripe Humana/epidemiología , Gripe Humana/virología , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa/métodos , Alemania/epidemiología , Humanos , Gripe Humana/diagnóstico , Reproducibilidad de los Resultados , Sensibilidad y Especificidad
6.
Acta Microbiol Immunol Hung ; 51(4): 469-84, 2004.
Artículo en Inglés | MEDLINE | ID: mdl-15704335

RESUMEN

The left part of the Epstein-Barr virus (EBV) genome exhibits a strong colinearity of structural and functional elements with the immunoglobulin (Ig) gene loci which is only partially reflected in nucleotide sequence homologies. We propose that this colinearity may be the result of an inter-dependent co-evolution of the immunoglobulin loci together with EBV. Our observation could help elucidating the mechanisms of somatic hypermutation, explaining the ability of EBV to accidentally cause tumors, and shedding more light on the general mechanisms of viral and organismal evolution. We suggest that persisting viruses served as a complement for the organismal germline like in a ping-pong game and outline The Ping-Pong Evolution Hypothesis.


Asunto(s)
Reordenamiento Génico , Genes de Inmunoglobulinas , Genoma Viral , Herpesvirus Humano 4/genética , Mapeo Cromosómico , Evolución Molecular , Humanos , Hipermutación Somática de Inmunoglobulina
7.
Exp Clin Endocrinol Diabetes ; 111(8): 486-90, 2003 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-14714270

RESUMEN

OBJECTIVE: We report two Hungarian patients with familial hypocalciuric hypercalcemia (FHH) caused by a mutation of the calcium-sensing receptor (CaSR) at codon 55. The proband and her father were heterozygous for this mutation. DESIGN: We performed detailed clinical and laboratory assessments of this family to characterize the effects of CaSR mutation on several endocrine organs expressing CaSR. RESULTS: Interestingly, we could not detect any failure in the function of any tissues we examined, except in serum calcium levels. CONCLUSIONS: To our knowledge, this has been the first report from Eastern and Central Europe showing P55 L mutation of the CaSR, as well as the first publication discussing the effect of this mutation on several endocrine systems containing CASR.


Asunto(s)
Calcio/metabolismo , Calcio/orina , Glándulas Endocrinas/fisiopatología , Genes Dominantes , Hipercalcemia/fisiopatología , Adulto , Secuencia de Bases , Densidad Ósea , Codón , Femenino , Heterocigoto , Humanos , Hipercalcemia/genética , Hipercalcemia/metabolismo , Hipercalcemia/orina , Masculino , Persona de Mediana Edad , Mutación , Receptores Sensibles al Calcio/genética
8.
Biol Chem ; 382(10): 1411-9, 2001 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-11727824

RESUMEN

The viral interleukin-10 promoter (vIL-10p), overlapping the rep* element in the Epstein-Barr virus (EBV) genome, is a promoter element active mostly in the late phase of the lytic cycle and immediately upon infection of B cells. rep* was, through transfection experiments with small plasmids, characterised as a cis element supporting oriP replicative function. In this study, in vivo protein binding and CpG methylation at rep*/vIL-10p were analysed in five cell lines that harbour strictly latent EBV genomes. Contrary to the invariably unmethylated dyad symmetry element (DS) of oriP, rep*/vIL-10p was highly methylated and showed only traces of protein binding in all examined cell lines. This result is in agreement with vIL-10p being an inactive promoter of EBV genomes, and makes it less likely that rep* functions as a replicative element of latent EBV genomes.


Asunto(s)
Islas de CpG , Metilación de ADN , ADN/metabolismo , Herpesvirus Humano 4/genética , Interleucina-10/genética , Linfocitos/virología , Proteínas/metabolismo , Secuencia de Bases , Línea Celular , Genoma Viral , Humanos , Linfocitos/citología , Datos de Secuencia Molecular , Regiones Promotoras Genéticas , Replicación Viral/genética
9.
Biol Chem ; 382(9): 1373-7, 2001 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-11688720

RESUMEN

Adenoviral DNA was examined within capsids by dimethyl sulfate footprinting. Protein-DNA interactions were visualized through ligation-mediated PCR (LM-PCR). Signals for protein binding were found adjacent to both inverted terminal repeats (ITR). There were no indications of close protein binding at several other loci of the viral genome. Therefore, adenovirus type 5 seems to contain sequence- or locus-specific DNA binding proteins within the virion.


Asunto(s)
Adenoviridae/genética , Cápside , Nucleoproteínas/metabolismo , Secuencia de Bases , Huella de ADN , ADN Viral/genética , ADN Viral/metabolismo , Humanos , Datos de Secuencia Molecular , Células Tumorales Cultivadas
10.
Scand J Immunol ; 54(1-2): 93-9, 2001.
Artículo en Inglés | MEDLINE | ID: mdl-11439154

RESUMEN

Macrophages play a central role in establishing a specific immune response by acting as professional antigen presenting cells (APC) for T cells leading to a vigorous immune response. In order to analyze if Herpes simplex Virus (HSV) type 1 infection might affect the macrophage APC-function, monocyte-derived human macrophages were infected with HSV-1 strain F in vitro. Cocultures with allogeneic T cells revealed a strongly impaired stimulatory capacity of HSV-infected macrophages compared to uninfected controls which was not owing to a productive viral infection in macrophages. An increased expression of Fas ligand (FasL/CD95L) was detected in HSV-infected macrophages by FACS analysis. Although the majority of the macrophages expressed high levels of Fas (CD95/Apo-1), the HSV-induced upregulation of FasL did not result in an increased autocrine apoptosis of macrophages which might be related to endogenous expression of the apoptosis inhibitor FLICE inhibitory protein (FLIP). However, substantial apoptosis occurred in peripheral T cells as well as Fas-sensitive Jurkat T cells when cocultured with HSV-infected macrophages. These findings suggest that the paracrine killing of activated T cells by FasL expressing APC might be a novel strategy of immune evasion by HSV.


Asunto(s)
Herpesvirus Humano 1/inmunología , Macrófagos/inmunología , Linfocitos T/inmunología , Apoptosis/inmunología , Células Cultivadas , Proteína Ligando Fas , Herpesvirus Humano 1/crecimiento & desarrollo , Humanos , Células Jurkat , Macrófagos/citología , Macrófagos/virología , Glicoproteínas de Membrana/biosíntesis , Monocitos/citología , Monocitos/inmunología , Linfocitos T/citología , Receptor fas/biosíntesis
11.
Biol Chem ; 382(4): 699-705, 2001 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-11405234

RESUMEN

We analysed the methylation patterns of CpG dinucleotides in a bidirectional promoter region (LRS, LMP 1 regulatory sequences) of latent Epstein-Barr virus (EBV) genomes using automated fluorescent genomic sequencing after bisulfite-induced modification of DNA. Transcripts for two latent membrane proteins, LMP 1 (a transforming protein) and LMP 2B, are initiated in this region in opposite directions. We found that B cell lines and a clone expressing LMP 1 carried EBV genomes with unmethylated or hypomethylated LRS, while highly methylated CpG dinucleotides were present at each position or at discrete sites and within hypermethylated regions in LMP 1 negative cells. Comparison of high resolution methylation maps suggests that CpG methylation-mediated direct interference with binding of nuclear factors LBF 2, 3, 7, AML1/LBF1, LBF5 and LBF6 or methylation of CpGs within an E-box sequence (where activators as well as repressors can bind) is not the major mechanism in silencing of the LMP 1 promoter. Although a role for CpG methylation within binding sites of Sp1 and 3, ATF/CRE and a sis-inducible factor (SIF) cannot be excluded, hypermethylation of LRS or regions within LRS in LMP 1 negative cells suggests a role for an indirect mechanism, via methylcytosine binding proteins, in silencing of the LMP 1 promoter.


Asunto(s)
ADN Viral/aislamiento & purificación , Genoma Viral , Herpesvirus Humano 4/genética , Regiones Promotoras Genéticas/genética , Proteínas de la Matriz Viral/genética , Islas de CpG/genética , Metilación de ADN , Humanos , Análisis de Secuencia , Latencia del Virus
12.
Antimicrob Agents Chemother ; 45(5): 1553-7, 2001 May.
Artículo en Inglés | MEDLINE | ID: mdl-11302827

RESUMEN

Of 94 clinical isolates of Staphylococcus aureus (n = 51) and coagulase-negative staphylococci (CNS) (n = 43), mutations in the quinolone resistance-determining region of topoisomerases GrlA, GrlB, GyrA, and GyrB together with MICs of six quinolones were analyzed. Amino acid substitutions at identical residues (GrlA residues 80 and 84; GyrA residues 84 and 88) were found in S. aureus and CNS. Active efflux, as suggested by blocking by reserpine, contributed substantially to the resistance phenotype in some strains. Among ciprofloxacin, clinafloxacin, levofloxacin, nalidixic acid, trovafloxacin, and sparfloxacin, a 0.5-microg/ml concentration of sparfloxacin discriminated best between strains with two or three mutations and those with no mutations.


Asunto(s)
Antiinfecciosos/farmacología , ADN-Topoisomerasas de Tipo I/genética , Staphylococcus aureus/genética , 4-Quinolonas , Coagulasa/análisis , Farmacorresistencia Microbiana/genética , Humanos , Pruebas de Sensibilidad Microbiana , Mutación , Staphylococcus aureus/efectos de los fármacos
13.
J Virol ; 75(6): 2584-96, 2001 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-11222681

RESUMEN

Epstein-Barr viral (EBV) latency-associated promoters Qp, Cp, and LMP1p are crucial for the regulated expression of the EBNA and LMP transcripts in dependence of the latency type. By transient transfection and in vitro binding analyses, many promoter elements and transcription factors have previously been shown to be involved in the activities of these promoters. However, the latency promoters have only partially been examined at the nucleotide level in vivo. Therefore, we undertook a comprehensive analysis of in vivo protein binding and CpG methylation patterns at these promoters in five representative cell lines and correlated the results with the known in vitro binding data and activities of these promoters from previous transfection experiments. Promoter activity inversely correlated with the methylation state of promoters, although Qp was a remarkable exception. Novel protein binding data were obtained for all promoters. For Cp, binding correlated well with promoter activity; for LMP1p and Qp, binding patterns looked similar regardless of promoter activity.


Asunto(s)
ADN Viral/metabolismo , Fosfatos de Dinucleósidos/metabolismo , Herpesvirus Humano 4/genética , Regiones Promotoras Genéticas/genética , Proteínas de la Matriz Viral/genética , Latencia del Virus , Linfoma de Burkitt , Línea Celular Transformada , Huella de ADN , Metilación de ADN , ADN Viral/genética , Proteínas de Unión al ADN/metabolismo , Regulación Viral de la Expresión Génica , Herpesvirus Humano 4/metabolismo , Humanos , Unión Proteica , Transcripción Genética , Células Tumorales Cultivadas , Proteínas de la Matriz Viral/metabolismo , Latencia del Virus/genética , Latencia del Virus/fisiología
14.
Arch Virol ; 143(10): 1967-83, 1998.
Artículo en Inglés | MEDLINE | ID: mdl-9856084

RESUMEN

The immediate early BRLF1 and BZLF1 promoters of Epstein-Barr virus are crucial for triggering the replicative cycle of the virus. To better understand the cell type dependence of the lytic cycle we conducted an analysis of the BRLF1-promoter in the epithelial cell line HeLa and the lymphoid cell line IM9. To analyze promoter activities, transient transfections with 5'-deletions of the BRLF1-promoter in front of luciferase as reporter gene were conducted. Besides the already known cis-acting elements of the promoter close to the TATA-box, more distal elements were located and functionally tested. A nuclear factor 1 consensus site was found to act positively in HeLa cells, but did not in lymphoid IM9 cells. The NF1 site was shown to bind protein by electrophoretic mobility shift assays, antibody-supershifts and in vitro footprinting. Thus, a protein belonging to the nuclear factor 1 family of proteins was identified as additional cellular trans-acting factor for the BRLF1-promoter besides the already described factors Sp1, Zta and Zif268.


Asunto(s)
Proteínas Potenciadoras de Unión a CCAAT , Proteínas de Unión al ADN/metabolismo , Genes Inmediatos-Precoces , Herpesvirus Humano 4/genética , Regiones Promotoras Genéticas , Factores de Transcripción/metabolismo , Sitios de Unión , Células HeLa , Humanos , Factores de Transcripción NFI , Proteínas Nucleares , Proteína 1 de Unión a la Caja Y
16.
J Biol Chem ; 270(21): 12864-8, 1995 May 26.
Artículo en Inglés | MEDLINE | ID: mdl-7759544

RESUMEN

Understanding protein-DNA interactions in vivo at origins of DNA replication throughout the cell cycle may shed further insight on the mechanisms of initiation and replication control. The Burkitt's lymphoma cell line Raji harbors multiple copies of latent Epstein-Barr virus. Once per cell cycle the origin of plasmid replication of Epstein-Barr virus provides replication function in cis for the viral DNA. Here we examined in vivo nucleoprotein complexes on the initiator element of the origin before and after DNA synthesis. For this purpose Raji cells were synchronously growth arrested in G1 phase by mimosine and in mitosis by colchicine, respectively. The association of the initiator element with proteins was visualized by footprinting with dimethyl sulfate and ligation mediated polymerase chain reaction. Methylation patterns indicated a novel binding activity within each element of a nonamer repeated three times at the initiator element. This activity was strongly diminished in mitotic cells. Furthermore, 5'-ends of Epstein-Barr virus DNA were mapped to the nonamers by ligation mediated polymerase chain reaction, suggesting potential initiation sites for replication from DS.


Asunto(s)
Ciclo Celular/genética , Replicación del ADN , ADN Viral/genética , Herpesvirus Humano 4/genética , Nucleoproteínas/análisis , Antígenos Virales/metabolismo , Secuencia de Bases , Linfoma de Burkitt , Ciclo Celular/efectos de los fármacos , Colchicina/farmacología , ADN/efectos de los fármacos , Proteínas de Unión al ADN/metabolismo , Antígenos Nucleares del Virus de Epstein-Barr , Fase G1/genética , Humanos , Mimosina/farmacología , Datos de Secuencia Molecular , Reacción en Cadena de la Polimerasa , Unión Proteica , Origen de Réplica , Fase S/genética , Ésteres del Ácido Sulfúrico/farmacología , Células Tumorales Cultivadas , Latencia del Virus
17.
Zentralbl Hyg Umweltmed ; 194(1-2): 118-25, 1993 Feb.
Artículo en Alemán | MEDLINE | ID: mdl-8392849

RESUMEN

Epstein-Barr virus is an ubiquitous humanpathogenic herpesvirus. It has been identified as the etiologic agent of infectious mononucleosis. In addition it is associated with the cancers nasopharyngeal carcinoma and Burkitt's lymphoma. Like other herpesviruses it infects cells in a lytic way or it persists in a latent state. Classically, the serologic diagnosis of Epstein-Barr virus infections is done by the agglutination of sheep erythrocytes according to Paul and Bunnell as a rapid testing method, and with the immunofluorescence assay. Lately, also the enzyme linked immunosorbent assay using recombinant viral antigens is used for Epstein-Barr virus diagnostics.


Asunto(s)
Linfoma de Burkitt/microbiología , Infecciones por Herpesviridae/microbiología , Herpesvirus Humano 4 , Animales , Antígenos Virales/análisis , Infecciones por Herpesviridae/diagnóstico , Herpesvirus Humano 4/aislamiento & purificación , Herpesvirus Humano 4/patogenicidad , Humanos , Mucosa Nasal/microbiología
18.
Mol Endocrinol ; 6(5): 793-804, 1992 May.
Artículo en Inglés | MEDLINE | ID: mdl-1318504

RESUMEN

Genomic clones containing 1.7 kilobases of the 5'-flanking region of the rat TSH receptor (TSHR) plus coding sequence from the ATG initiation codon [1 basepair (bp)] to the start of the first intron (170 bp) have been isolated and characterized. RNAase protection, primer extension, and cDNA sequences cloned by the anchored polymerase chain reaction identified multiple transcriptional start sites, the major ones clustered between -89 to -68 bp. This portion of the 5'-flanking region has neither a TATA nor a CCAAT box, is GC rich but has no GC box motif, and has features of promoters seen in "housekeeping" genes. Chimeras containing 1.7 kilobases (-1707 to -2 bp) of the 5'-flanking region, or deletions thereof, and the bacterial chloramphenicol acetyltransferase (CAT) gene expressed significant CAT activity when transfected into rat thyroid cell lines, FRTL-5 and FRT, but not BRL rat liver or HeLa cells. TSH decreased CAT activity in the FRTL-5 thyroid cells that had been stably transfected with the TSHR-CAT chimeric constructs. Negative regulation of promoter activity by TSH was duplicated by 10 microM forskolin in FRT thyroid cells, which express no TSHR mRNA. Deletion analyses indicated that a "minimal" region, exhibiting promoter activity, tissue specificity, and negative regulation by TSH, is located between -195 and -39 bp; this region is highly conserved in rat and human TSHR genes. Differential digestion of genomic DNA by MspI and HpaII revealed that the TSHR promoter is methylated in FRT, but not FRTL-5, cells; methylation of the promoter may be associated with loss of endogenous TSHR gene expression in FRT cells.


Asunto(s)
Receptores de Tirotropina/genética , Secuencia de Aminoácidos , Animales , Secuencia de Bases , Células Cultivadas , Cloranfenicol O-Acetiltransferasa/metabolismo , AMP Cíclico/fisiología , Receptores ErbB/genética , Hidroximetilglutaril-CoA Reductasas/genética , Datos de Secuencia Molecular , Especificidad de Órganos/genética , Regiones Promotoras Genéticas , Ratas , Homología de Secuencia de Ácido Nucleico , Virus 40 de los Simios/genética , Glándula Tiroides/fisiología , Tirotropina/fisiología
19.
Nucleic Acids Res ; 19(13): 3715-21, 1991 Jul 11.
Artículo en Inglés | MEDLINE | ID: mdl-1649457

RESUMEN

The major immediate early enhancer of the human cytomegalovirus (HCMV) is composed of unique and repeated sequence motifs, which interact with different nuclear proteins, thus forming a large nucleoprotein complex. Using DNAase I protection analysis, we determined at the nucleotide level the interactions of B cell and HeLa cell nuclear proteins with transcription factor binding sites in the enhancer/promoter. In agreement with in vivo activity, protein binding to the 18 bp repeats (kappa B element) was found predominantly with B cell extract. Competition for proteins with individual transcription factor binding sites allowed us to define boundaries of closely spaced and overlapping binding sites, and to group binding proteins into several classes. Using gel mobility shift assays, we could show that proteins, which bind to the 17 bp repeat, also bind to a classical NF1 site. In addition, several novel binding sites were identified. The presence of overlapping binding sites, together with differences in the occupation of the 18 bp repeats in the two cell types, suggest that the HCMV major IE enhancer has several possibilities of forming nucleoprotein complexes.


Asunto(s)
Citomegalovirus/genética , Elementos de Facilitación Genéticos/fisiología , Nucleoproteínas/metabolismo , Linfocitos B , Secuencia de Bases , Sitios de Unión/genética , Sitios de Unión/fisiología , Fraccionamiento Celular , Cromatografía en Gel , Secuencia de Consenso/fisiología , Desoxirribonucleasa I/metabolismo , Células HeLa , Humanos , Datos de Secuencia Molecular , Proteínas Nucleares/metabolismo , Oligonucleótidos/metabolismo , Plásmidos/genética , Secuencias Repetitivas de Ácidos Nucleicos/genética , Transfección/genética , Células Tumorales Cultivadas
20.
J Virol ; 64(5): 2388-91, 1990 May.
Artículo en Inglés | MEDLINE | ID: mdl-2157893

RESUMEN

The 19-base-pair enhancer repeat of the human cytomegalovirus immediate-early 1 gene mediates cyclic AMP- and phytohemagglutinin-induced expression in Jurkat T cells. Synergistic activity was observed in the presence of both drugs, suggesting a convergence of the protein kinase A and C pathways on this transcription element. In addition, the immunosuppressive drug cyclosporine strongly reduced the ability of the 19-base-pair repeat to activate gene expression in phytohemagglutinin-stimulated T cells.


Asunto(s)
AMP Cíclico/farmacología , Ciclosporinas/farmacología , Citomegalovirus/genética , Elementos de Facilitación Genéticos/efectos de los fármacos , Expresión Génica/efectos de los fármacos , Genes Virales/efectos de los fármacos , Fitohemaglutininas/farmacología , Secuencia de Bases , Línea Celular , Citomegalovirus/efectos de los fármacos , Humanos , Datos de Secuencia Molecular , Secuencias Repetitivas de Ácidos Nucleicos , Transcripción Genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...